Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Interim Management Statement

17 Jan 2008 15:23

Aberdeen Income & Growth VCT PLC17 January 2008 Aberdeen Income and Growth VCT PLC ("the Company") Interim Management Statement - Quarter ended 30 November 2007 This Interim Management Statement, for the quarter ended 30 November 2007, isprovided in accordance with Rule 4.3 of the Disclosure and Transparency Rules ofthe UK Listing Authority and also includes relevant information in respect ofthe period from 1 December 2007 to the date of issue. This Statement has beenprepared solely to provide additional information in order to meet the relevantrequirements of the UK Listing Authority's Disclosure and Transparency Rules,and should not be relied on by Shareholders, or any other party, for any otherpurpose. 1. Financial highlights • Net Asset Value* ("NAV") of 77.5p per share at 30 November 2007 compared to 77.4p per share at 31 August 2007. • Interim dividend dividends totalling 3.5p per share paid on 7 December 2007. \* The NAV is unaudited and reflects the closing bid price of quoted securities at 30 November 2007. Unlisted companies are valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 31 August 2007. 2. Investments and Disposals During the quarter ended 30 November 2007, investments totalling £1,950,000 weremade in 9 unlisted or AIM/PLUS quoted companies. During the same period, a combination of partial and complete disposals of 5 AIMquoted investments generated aggregate proceeds of £64,000 against cost of£45,000. There were no other material transactions during the period under review. 3. Recent developments Between 30 November 2007 and the date of this statement, investments totalling£629,000 were made in 2 unlisted companies and 1 AIM quoted company. During the same post quarter-end period, disposals of listed fixed incomesecurities generated aggregate proceeds of £1,394,000 against cost of £1,384,000and disposals of 3 unlisted investments and 1 AIM quoted investment generatedaggregate proceeds of £2,294,000 against cost of £2,028,000. Included in thesedisposals was the sale of the unlisted investment in TLC (Tender LovingChildcare), which generated proceeds of £1,620,000 against a cost of £1,516,000. Other than described above, Board is not aware of any material events during theperiod from 1 September 2007 to 30 November 2007, or in the period from 1December 2007 to the date of this announcement, which would have had a materialimpact on the financial position of the Company. Issued on behalf of the BoardMurray Johnstone Limited, Secretary17 January 2008 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Jun 20234:21 pmRNSAnnual Financial Report
2nd Jun 20239:39 amRNSIssue of Equity
1st Jun 202312:18 pmRNSNet Asset Value(s)
26th May 20233:53 pmRNSTransaction in Own Shares
24th May 202310:52 amRNSUnaudited NAV and Proposed Final Dividend
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
5th Apr 202312:33 pmRNSDirector/PDMR Shareholding
5th Apr 202312:26 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
3rd Mar 202310:37 amRNSDirector/PDMR Shareholding
3rd Mar 202310:35 amRNSDirector/PDMR Shareholding
3rd Mar 202310:35 amRNSDirector/PDMR Shareholding
3rd Mar 20239:47 amRNSIssue of Equity
21st Feb 20234:39 pmRNSTransaction in Own Shares
6th Feb 20234:23 pmRNSNet Asset Value(s)
2nd Dec 20229:30 amRNSIssue of Equity
25th Nov 202212:36 pmRNSStatement re Dividend Investment Scheme
9th Nov 20222:34 pmRNSResult of General Meeting
4th Nov 202211:15 amRNSHalf-year Report
26th Oct 20223:50 pmRNSTransaction in Own Shares
14th Oct 20223:33 pmRNSNet Asset Value and Interim Dividend
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
5th Aug 20224:39 pmRNSTransaction in Own Shares
15th Jul 202211:08 amRNSIssue of Equity
11th Jul 20223:12 pmRNSStatement re Dividend Investment Scheme
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
8th Jul 20222:36 pmRNSNet Asset Value(s)
7th Jul 20222:34 pmRNSResult of AGM
8th Jun 20222:12 pmRNSAnnual Financial Report
29th Apr 20222:28 pmRNSTransaction in Own Shares
27th Apr 20224:04 pmRNSTransaction in Own Shares
21st Apr 202211:22 amRNSStatement re NAV and Proposed Final Dividend
25th Jan 20224:04 pmRNSTransaction in Own Shares
21st Jan 20223:15 pmRNSNet Asset Value(s)
3rd Dec 20219:48 amRNSIssue of Equity
26th Nov 20219:53 amRNSStatement re Dividend Investment Scheme
12th Nov 20214:31 pmRNSHalf-year Report
11th Nov 20214:23 pmRNSTransaction in Own Shares
9th Nov 20211:33 pmRNSTransaction in Own Shares
27th Oct 20214:44 pmRNSNet Asset Value and Interim Dividend
20th Sep 20214:57 pmRNSStatement re Change of Registrar
16th Jul 202110:04 amRNSIssue of Equity
12th Jul 20214:28 pmRNSStatement re Dividend Investment Scheme
7th Jul 20213:32 pmRNSNet Asset Value(s)
7th Jul 202112:37 pmRNSResult of AGM
4th Jun 20214:16 pmRNSAnnual Financial Report
4th May 20213:37 pmRNSIssue of Equity
20th Apr 20214:56 pmRNSTransaction in Own Shares
16th Apr 20214:40 pmRNSNet Asset Value and Proposed Final Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.